Precision Neuro Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 77

Employees

  • Latest Deal Type
  • Series C

  • Latest Deal Amount
  • $102M

  • Investors
  • 10

Precision Neuro General Information

Description

Developer of a brain-computer interface device technology designed to provide effective treatment for patients with neurological illnesses. The company's thin-film microelectrode array conforms to the brain surface without penetrating tissue, collecting and processing large amounts of neural data across multiple brain regions, enabling medical providers to treat conditions such as spinal cord injuries, stroke, and neurodegenerative diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 54 West 21st Street
  • Suite 301
  • New York, NY 10010
  • United States
+1 (646)
Primary Industry
Therapeutic Devices
Other Industries
Other Healthcare Technology Systems
Corporate Office
  • 54 West 21st Street
  • Suite 301
  • New York, NY 10010
  • United States
+1 (646)

Precision Neuro Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Precision Neuro Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC (Series C) 16-Dec-2024 $102M Completed Generating Revenue
2. Early Stage VC (Series B) 25-Jan-2023 Completed Pre-Clinical Trials
1. Early Stage VC (Series A) 25-May-2021 $12M $12M Completed Pre-Clinical Trials
To view Precision Neuro’s complete valuation and funding history, request access »

Precision Neuro Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C
Series C-1
Series B 16,835,784 $0.000100 $2.44 $2.44 1x $2.44 18.45%
Series A 11,999,995 $0.000100 $1 $1 1x $1 13.15%
To view Precision Neuro’s complete cap table history, request access »

Precision Neuro Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a brain-computer interface device technology designed to provide effective treatment for patients with neur
Therapeutic Devices
New York, NY
77 As of 2025

Fremont, CA
 

New York, NY
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Precision Neuro Competitors (15)

One of Precision Neuro’s 15 competitors is Neuralink, a Venture Capital-Backed company based in Fremont, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Neuralink Venture Capital-Backed Fremont, CA
Synchron Venture Capital-Backed New York, NY
Kernel (Monitoring Equipment) Venture Capital-Backed Los Angeles, CA
Blackrock Neurotech Venture Capital-Backed Salt Lake City, UT
Paradromics Venture Capital-Backed Austin, TX
You’re viewing 5 of 15 competitors. Get the full list »

Precision Neuro Patents

Precision Neuro Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20250130641-A1 Systems and methods for self-calibrating neural decoding Pending 20-Oct-2023
US-20250114024-A1 Systems and methods for visualizing brain activity in real time at high spatial and temporal resolution Pending 06-Oct-2023
US-20250068240-A1 Wireless implant system emergency shutdown Pending 22-Aug-2023
US-20240374207-A1 Methods and systems for detecting and monitoring high-resolution electrocorticographic features of neurological states Pending 08-May-2023
US-20240291504-A1 Data compression for neural systems Pending 28-Feb-2023 H03M7/70
To view Precision Neuro’s complete patent history, request access »

Precision Neuro Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Precision Neuro Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
Chestnut Street Ventures Venture Capital Minority
Duquesne Family Office Family Office Minority
General Equity Holdings Hedge Fund Minority
Alumni Ventures Venture Capital Minority
Draper Associates Venture Capital Minority
You’re viewing 5 of 10 investors. Get the full list »

Precision Neuro Investments (1)

Precision Neuro’s most recent deal was a Corporate Asset Purchase with Precision Neuroscience (Manufacturing Facility in Dallas, Texas). The deal was made on 05-Oct-2023.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Precision Neuroscience (Manufacturing Facility in Dallas, Texas) 05-Oct-2023 Corporate Asset Purchase Buildings and Property
To view Precision Neuro’s complete investments history, request access »

Precision Neuro FAQs

  • When was Precision Neuro founded?

    Precision Neuro was founded in 2021.

  • Where is Precision Neuro headquartered?

    Precision Neuro is headquartered in New York, NY.

  • What is the size of Precision Neuro?

    Precision Neuro has 77 total employees.

  • What industry is Precision Neuro in?

    Precision Neuro’s primary industry is Therapeutic Devices.

  • Is Precision Neuro a private or public company?

    Precision Neuro is a Private company.

  • What is the current valuation of Precision Neuro?

    The current valuation of Precision Neuro is .

  • What is Precision Neuro’s current revenue?

    The current revenue for Precision Neuro is .

  • How much funding has Precision Neuro raised over time?

    Precision Neuro has raised $155M.

  • Who are Precision Neuro’s investors?

    Chestnut Street Ventures, Duquesne Family Office, General Equity Holdings, Alumni Ventures, and Draper Associates are 5 of 10 investors who have invested in Precision Neuro.

  • Who are Precision Neuro’s competitors?

    Neuralink, Synchron, Kernel (Monitoring Equipment), Blackrock Neurotech, and Paradromics are some of the 15 competitors of Precision Neuro.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »